Patent details

300769 Product Name: Everolimus, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout.

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
300769
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2269603
Status:
Refused Art. 10 of the EC Regulations
Application number:
300769
Procedural language:
Dutch
First Applicant Residence Country:
Switzerland (CH)

Marketing Authorization

Marketing Authorization Number:
EU/1/09/001, 003, 004 en 006-010 (C(2012)5347)
Marketing Authorization Type:
EEA
Marketing Authorization Date:
25/07/2012
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
09/11/2015
First Marketing Authorization date:
25/07/2012
Grant date:
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
11/12/2015
SPC/SPC Extension Expiration Date:
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
23/07/2020

Applicant/holder

From:
26/09/2018
 
 

 

Name:
Novartis Pharma AG
Address:
Lichtstrasse 35, 4056, Basel, Switzerland (CH)

From:
26/09/2018
 
 

 

Name:
Novartis International Pharmaceutical AG
Address:
Lichtstrasse 35, 4056, Basel , Switzerland (CH)

Historical Applicant/holder

From:
09/11/2015
To:
26/09/2018

 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 BASEL, Switzerland (CH)

Agent

Name:
ir. M.F.J.M. Ketelaars c.s.
From:
11/12/2015
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Licensee

Name:
Novartis Pharma B.V.
From:
10/05/2019
Address:
Raapopseweg 1, 6824 DP, Arnhem, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
31/20
Publication date:
31/07/2020
Description:
Lapse or annulment

2

Bulletin Heading:
VRV
Journal edition number:
51/19
Publication date:
18/12/2019
Description:
Lapse or annulment

3

Bulletin Heading:
MED
Journal edition number:
25/19
Publication date:
19/06/2019
Description:
Other communications

4

Bulletin Heading:
CO
Journal edition number:
49/18
Publication date:
28/11/2018
Description:
Changes in the Netherlands Patent Register

5

Bulletin Heading:
SPC
Journal edition number:
51/15
Publication date:
16/12/2015
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Deed

Licence

Change Kind/ Decision Type:
New licence registration
Deed Number:
RC201900908A
Date Registered:
10/05/2019
License Effective Date:
10/05/2018
License Expiration Date:
Scope of License:
Not Exclusive
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Netherlands (NL)
Updated License Number:
Terminated License Number:

Added Licensee(s)

Name:
Novartis Pharma B.V.
Address:
Raapopseweg 1, 6824 DP, Arnhem, Netherlands (NL)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC201801726A
Date Registered:
26/09/2018
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

1

Name:
Novartis Pharma AG
Address:
Lichtstrasse 35, 4056, Basel, Switzerland (CH)

2

Name:
Novartis International Pharmaceutical AG
Address:
Lichtstrasse 35, 4056, Basel , Switzerland (CH)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:
Filing date Document type Document Description Number of pages File Type
23/07/2020 Outgoing Correspondence Decision refusal 2 PDF /5/7/3/9/1/0800019375/docs/300769_13_355800l527a.pdf
14/04/2020 Outgoing Correspondence Letter to applicant 1 PDF /5/7/3/9/1/0800019375/docs/300769_9_338568l173.pdf
26/09/2016 Outgoing Correspondence Outgoing Letter 1 PDF /5/7/3/9/1/0800019375/docs/300769_6_outgoingcorrespondence20160926021041410.pdf
20/09/2016 Incoming Correspondence Paper Accompanying letter incoming document 1 PDF /5/7/3/9/1/0800019375/docs/300769_5_incomingcorrespondencepaper20160921033609233.pdf
28/06/2016 Outgoing Correspondence Outgoing Letter 1 PDF /5/7/3/9/1/0800019375/docs/300769_0_outgoingcorrespondence20160628110453134.pdf
21/06/2016 Incoming Correspondence Paper Accompanying letter incoming document 1 PDF /5/7/3/9/1/0800019375/docs/300769_11_incomingcorrespondencepaper20160627035853248.pdf
23/03/2016 Outgoing Correspondence Letter to applicant 3 PDF /5/7/3/9/1/0800019375/docs/300769_3_outgoingcorrespondence20160325101841213.pdf
11/12/2015 Outgoing Correspondence Outgoing Letter 1 PDF /5/7/3/9/1/0800019375/docs/300769_12_21596l174.pdf
24/11/2015 Incoming Correspondence Paper Accompanying letter incoming document 1 PDF /5/7/3/9/1/0800019375/docs/300769_14_incomingcorrespondencepaper20151211025534257.pdf
09/11/2015 SPC Documents Summary of the characteristics of the product 37 PDF /5/7/3/9/1/0800019375/docs/300769_1_supplprotectioncertificate20210330034151848.pdf
09/11/2015 SPC Documents Annex SPC 17 PDF /5/7/3/9/1/0800019375/docs/300769_2_supplprotectioncertificate20210330034152019.pdf
09/11/2015 SPC Documents Annex SPC 3 PDF /5/7/3/9/1/0800019375/docs/300769_4_supplprotectioncertificate20210330034151930.pdf
09/11/2015 SPC Documents Annex SPC 8 PDF /5/7/3/9/1/0800019375/docs/300769_7_supplprotectioncertificate20200409104903310.pdf
09/11/2015 SPC Documents Marketing Authorization SPC 4 PDF /5/7/3/9/1/0800019375/docs/300769_8_supplprotectioncertificate20200409105057471.pdf
09/11/2015 Application Form First filed application form 2 PDF /5/7/3/9/1/0800019375/docs/300769_10_applicationform20151210123154955.pdf
09/11/2015 SPC Documents Annex SPC 2 PDF /5/7/3/9/1/0800019375/docs/300769_15_supplprotectioncertificate20200409104531471.pdf
09/11/2015 SPC Documents Accompanying letter SPC 3 PDF /5/7/3/9/1/0800019375/docs/300769_16_supplprotectioncertificate20210330032908270.pdf